STOCK TITAN

Pacira BioSciences to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

PACIRA BIOSCIENCES, INC. (NASDAQ: PCRX) will present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 7:30 AM ET. Investors can access the live audio via the company's website. A replay will be available for two weeks post-event. Pacira is a leader in non-opioid pain management and regenerative health solutions, known for its long-acting local analgesic, EXPAREL®. The company acquired the handheld cryoanalgesia device, iovera⁰, in April 2019 to further its mission of reducing opioid reliance.

Positive
  • None.
Negative
  • None.

PARSIPPANY, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 39th Annual J.P. Morgan Healthcare Conference at 7:30 AM ET on Wednesday, January 13, 2021. Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira         

Pacira BioSciences, Inc. (NASDAQ: PCRX) is the leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, the company acquired the iovera⁰ system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.


FAQ

When will Pacira present at the J.P. Morgan Healthcare Conference?

Pacira will present at the J.P. Morgan Healthcare Conference on January 13, 2021, at 7:30 AM ET.

How can I listen to Pacira's presentation at the conference?

You can listen to the live audio of Pacira's presentation by visiting the 'Events' page on their website.

What is the stock symbol for Pacira BioSciences?

The stock symbol for Pacira BioSciences is PCRX.

What product does Pacira offer for pain management?

Pacira offers EXPAREL®, a long-acting local analgesic for pain management.

What technology does EXPAREL® utilize?

EXPAREL® utilizes DepoFoam®, a proprietary product delivery technology that releases drugs over time.

What device did Pacira acquire in April 2019?

In April 2019, Pacira acquired the iovera⁰ system, a handheld cryoanalgesia device.

Pacira BioSciences, Inc.

NASDAQ:PCRX

PCRX Rankings

PCRX Latest News

PCRX Stock Data

758.10M
45.12M
2.15%
114.91%
11.84%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
TAMPA